Supernus Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.About SUPN
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products.
CEOJack A. Khattar
CEOJack A. Khattar
Employees674
Employees674
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2005
Founded2005
Employees674
Employees674
SUPN Key Statistics
Market cap2.60B
Market cap2.60B
Price-Earnings ratio-133.27
Price-Earnings ratio-133.27
Dividend yield—
Dividend yield—
Average volume658.93K
Average volume658.93K
High today$47.19
High today$47.19
Low today$45.36
Low today$45.36
Open price$47.01
Open price$47.01
Volume584.06K
Volume584.06K
52 Week high$57.65
52 Week high$57.65
52 Week low$29.16
52 Week low$29.16
Stock Snapshot
With a market cap of 2.6B, Supernus Pharmaceuticals(SUPN) trades at $45.42. The stock has a price-to-earnings ratio of -133.27.
As of 2025-12-09, Supernus Pharmaceuticals(SUPN) stock has fluctuated between $45.36 and $47.19. The current price stands at $45.42, placing the stock +0.1% above today's low and -3.7% off the high.
Supernus Pharmaceuticals(SUPN) shares are trading with a volume of 584.06K, against a daily average of 658.93K.
During the past year, Supernus Pharmaceuticals(SUPN) stock moved between $29.16 at its lowest and $57.65 at its peak.
During the past year, Supernus Pharmaceuticals(SUPN) stock moved between $29.16 at its lowest and $57.65 at its peak.
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own SUPN. This list is generated using Robinhood data, and it’s not a recommendation.